Skip to main content
OpenTrials
Completed

NCT Number: NCT02324504

Evaluation of Electrocardiographic Guidance in Accurate Peripherally Inserted Central Catheter Placement in Children.

This study will enroll up to 192 children less than 18 years of age, who will receive electrocardiographic guidance for placement of a PICC in addition to radiography done as standard care. The investigators will determine the location of the PICC tip from both ECG and radiograph, and then measure the degree of correlation between the two methods.

Completed

Looking for future studies?

Notify Me

Key information

Age range

Up to 17 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Boston Children's Hospital

Boston, Massachusetts, 02115, United States

About this study

The placement of peripherally inserted central catheters (PICCs) is an important component of medical care for a variety of patients. Current practice requires radiographic confirmation of catheter tip placement prior to use of the line for administration of medications. Often the final catheter tip position may be uncertain based on radiographic imaging. Other times, the catheter is malpositioned and requires adjustment and repeat radiographic imaging. In adult patients, a system of confirmation that is based on electrocardiographic activity has been implemented and is FDA approved. This study will enroll up to 192 children less than 18 years of age who will receive electrocardiographic guidance for placement of a PICC, in addition to radiography done as standard care. The investigators will determine the location of the PICC tip from both ECG and radiograph, and then measure the degree of correlation between the two methods.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age from birth to 17 years in need of a PICC as part of the medical treatment plan
  • Suitable for an upper extremity PICC placement
  • Hemodynamically stable, including patients stable on vasopressors

Exclusion criteria

  • Hemodynamic instability
  • Cardiac abnormality which leads to abnormal p-wave on ECG
  • Arrhythmia at baseline, documented duirng the current hospital admission
  • Presence of pacemaker or pacing wires which are currently actively pacing
  • Patients who have undergone reconstructive cardiac surgery and/or have anatomic variance that would affect the location of the sinoatrial node in relation to the superior vena cava
  • Premature neonate (<37 weeks estimated gestational age)
  • Placement of PICC in lower extremity

Treatment and study plan

C3 Wave ECG-based PICC Tip Confirmation System

Device

The C3 Wave PICC tip detection system will be used to identify catheter tip location during the procedural placement of the catheter. This system includes an ECG monitor that will be connected to the guidewire used for catheter placement. The changes in the ECG tracing will guide correct catheter placement.

Primary outcomes

  1. Number of Participants With Successful Placement of Peripherally Inserted Central Catheter (PICC)

    Time frame: Less than 24 hours

    Successful placement (based upon review of chest radiograph) of the PICC as determined by the tip location of:

    • RA SVC junction (right atrium/superior vena cava) or
    • Distal or lower SVC

Sponsors and collaborators

Lead sponsor

Boston Children's Hospital

Other

Registry information

Acronym: ECG-PICC

Important dates

Study start
2016
Primary completion
2016
Study completion
2017
First posted
Dec 24, 2014
Registry last updated
Jul 25, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.